[The mycota-confusion: commentary on the discussion mycota-immunological background of the chronic rhinosinusitis with or without polyposis].
Stammberger
H
H
D000281:Administration, Intranasal; D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use; D001798:Blood Proteins / Q000378:metabolism*; D002908:Chronic Disease; D003937:Diagnosis, Differential; D047091:Eosinophil Granule Proteins; D004802:Eosinophilia / Q000276:immunology / Q000382:microbiology; D005658:Fungi / Q000276:immunology*; D006801:Humans; D009181:Mycoses / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D009297:Nasal Mucosa / Q000378:metabolism* / Q000382:microbiology; D020545:Respiratory Mucosa / Q000187:drug effects / Q000276:immunology / Q000382:microbiology; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology* / Q000382:microbiology; D012260:Ribonucleases / Q000378:metabolism*; D012852:Sinusitis / Q000276:immunology* / Q000382:microbiology
D000935:Antifungal Agents; D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D000666:Amphotericin B; D012260:Ribonucleases